]>
IRCT20230219057453N1 IRCT 2023-03-27 Tehran University of Medical Sciences Investigating the impact of the empowerment program on psoriasis patients Investigating the impact of a comprehensive remote empowerment program on the quality of life and medication adherence of patients with psoriasis 2023-04-02 anticipated 52 Complete https://irct.ir/trial/68930 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: during two stages; The first step is the convenience sampling. In the second stage, patients will be allocated in two intervention and control groups by random block allocation method. The samples are randomly assigned to quadruple blocks A, A, B, B in random groups. So that 16 blocks of 4 letters A and B are made up.Then a block is randomly selected. RAS random allocation software will be used to randomly select blocks. A indicates sample placement in intervention group and B indicates sample placement in control group. First, a block will be randomly identified by RAS software and then the first eligible sample will be entered into the intervention or control group according to the order of the letters A or B. Sampling will continue until all samples are selected. N/A psoriasis. Intervention 1: Intervention group: At the beginning of the study, the study questionnaires including demographic information questionnaire, perceived stigma, quality of life and medication adherence were completed by the patients of both control and intervention groups. This study will be conducted for 7 weeks and the control group will receive the usual care, while the patients of the intervention group will also receive the comprehensive empowerment program in addition to the usual care. In this way, the intervention group will be joined by the researcher in virtual groups of 10 to 15 people in the WhatsApp social network and will receive the comprehensive empowerment program. In this research, a 7-week empowerment program will be held online and on the platform of virtual networks according to the patients' conditions, and each week will address a specific topic to promote self-care. The content of each of the sessions will be provided to all patients of the intervention group in the same way as a combination of online and offline sessions (4 online sessions and 3 offline sessions) with an interval of one week for 7 weeks. Or the training video will be sent in the virtual network groups and in the online meetings, the Skyroom link will be placed in the virtual network group to hold online group meetings. Online group meetings with members of groups of 10 to 15 people will be held on the virtual network for 10 minutes and through the Skyroom platform. became. Intervention 2: Control group: Control group: study questionnaires including demographic information questionnaire, perceived stigma, quality of life and drug treatment adherence are completed by patients of both control and intervention groups. This study will be conducted in 7 weeks and the control group will receive the usual care. Yes - There is a plan to make this available What will be shared: All data can be shared after de-identifying the participants When: Start access after receiving information and data forever To whom: All applicants working in academic and scientific institutions Conditions: The use of data and documents in scientific research is unimpeded. Where to obtain: ایمیل arasti@tums.ac.ir How to obtain: Apply by email and after receiving the email up to 2 months later Comments:
public sayede Sara Mirhosseini
Tehran, Kargarshamali Street, Amirabad, Dormitory of Medical Sciences for Girls
tehran Iran (Islamic Republic of) 1439955975 +98 930 264 4173 saramirhosseini1400@gmail.com Tehran University of Medical Sciences scientific dr Arezoo Rasti
Tawheed Square, Nosrat St., Faculty of Nursing and Midwifery, Tehran
Tehran Iran (Islamic Republic of) 1419733171 +98 21 6692 7171 arasti@tums.ac.ir Tehran University of Medical Sciences Iran (Islamic Republic of) Personal consent of the person to participate in the program Adults 18 to 65 years old Medical diagnosis of psoriasis according to the patient's medical record Being in a stable state of illness Having at least reading and writing literacy Ability to communicate Access and ability to use a smart phone and the Internet 18 years 65 years Both Diagnosed mental and cognitive disorders Previous participation in similar empowerment programs History of suicide L40 Psoriasis Other Other Intervention group: At the beginning of the study, the study questionnaires including demographic information questionnaire, perceived stigma, quality of life and medication adherence were completed by the patients of both control and intervention groups. This study will be conducted for 7 weeks and the control group will receive the usual care, while the patients of the intervention group will also receive the comprehensive empowerment program in addition to the usual care. In this way, the intervention group will be joined by the researcher in virtual groups of 10 to 15 people in the WhatsApp social network and will receive the comprehensive empowerment program. In this research, a 7-week empowerment program will be held online and on the platform of virtual networks according to the patients' conditions, and each week will address a specific topic to promote self-care. The content of each of the sessions will be provided to all patients of the intervention group in the same way as a combination of online and offline sessions (4 online sessions and 3 offline sessions) with an interval of one week for 7 weeks. Or the training video will be sent in the virtual network groups and in the online meetings, the Skyroom link will be placed in the virtual network group to hold online group meetings. Online group meetings with members of groups of 10 to 15 people will be held on the virtual network for 10 minutes and through the Skyroom platform. became. Control group: Control group: study questionnaires including demographic information questionnaire, perceived stigma, quality of life and drug treatment adherence are completed by patients of both control and intervention groups. This study will be conducted in 7 weeks and the control group will receive the usual care. Treatment compliance. Timepoint: Before the intervention, 2 weeks and 4 weeks after the intervention. Method of measurement: Moriski medication adherence questionnaire. Quality of life. Timepoint: Before the intervention, 2 weeks and 4 weeks after the intervention. Method of measurement: Questionnaire of quality of life of World Health Organization,. Stigma. Timepoint: Before starting the intervention, 2 weeks and 4 weeks after the intervention. Method of measurement: Geisenberg et al.'s questionnaire. Tehran University of Medical Sciences Approved 2023-02-17 Ethics Committee of Faculty of Nursing and Midwifery, Tehran University of Medical Sciences Shahvarz Blvd., corner of Qods St., Tehran University of Medical Sciences Tehran Tehran Iran (Islamic Republic of)